Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder

NCT00467402 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

644

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: agomelatine
DRUG: placebo

Sponsor

Novartis